These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31877224)

  • 1. Safety and Bioavailability of Complete and Half-Dose Intravitreal Ziv-Aflibercept in an Experimental Model: Contralateral Eye Study.
    Lashay A; Delrish E; Ashrafi E; Movassat M; Asadi-Amoli F; Dinarvand R; Abrishami M
    Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):785-790. PubMed ID: 31877224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular Pharmacokinetics of Intravitreal Aflibercept (Eylea) in a Rabbit Model.
    Park SJ; Choi Y; Na YM; Hong HK; Park JY; Park KH; Chung JY; Woo SJ
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2612-7. PubMed ID: 27258433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Ziv-Aflibercept : Safety Analysis in Eyes Receiving More Than Ten Intravitreal Injections.
    Singh SR; Chattannavar G; Ayachit A; Pimentel MC; Alfaro A; Tiwari S; Heranjal A; Subramanyam A; Braimah IZ; Dhami A; Sachdev P; Mansour A; Chhablani J
    Semin Ophthalmol; 2020 Jan; 35(1):2-6. PubMed ID: 31690175
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical investigations of intravitreal ziv-aflibercept.
    de Oliveira Dias JR; Badaró E; Novais EA; Colicchio D; Chiarantin GM; Matioli MM; Verna C; Penha FM; Barros NM; Meyer CH; Farah ME; Rodrigues EB
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):577-84. PubMed ID: 25423640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study.
    Andrade GC; Dias JR; Maia A; Farah ME; Meyer CH; Rodrigues EB
    Retina; 2016 Sep; 36(9):1640-5. PubMed ID: 26991646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.
    Park SJ; Oh J; Kim YK; Park JH; Park JY; Hong HK; Park KH; Lee JE; Kim HM; Chung JY; Woo SJ
    Eye (Lond); 2015 Apr; 29(4):561-8. PubMed ID: 25592118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of 5914 intravitreal ziv-aflibercept injections.
    Singh SR; Stewart MW; Chattannavar G; Ashraf M; Souka A; ElDardeery M; Wadhwa N; Sarvaiya C; Mansour AM; Marashi A; Ramchandani S; Braimah IZ; Jabbarpoor Bonyadi MH; Ramezani A; Soheilian M; de Oliveira Dias JR; de Andrade GC; Maia A; Rodrigues EB; Farah ME; Banker A; Chhablani J;
    Br J Ophthalmol; 2019 Jun; 103(6):805-810. PubMed ID: 30099379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHORT-TERM SAFETY PROFILE OF INTRAVITREAL ZIV-AFLIBERCEPT.
    Chhablani J; Narayanan R; Mathai A; Yogi R; Stewart M
    Retina; 2016 Jun; 36(6):1126-31. PubMed ID: 26655620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion.
    Braimah IZ; Singh SR; Uplanchiwar B; Mansour AM; Chhablani J
    Indian J Ophthalmol; 2019 Jul; 67(7):1109-1113. PubMed ID: 31238422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes.
    Niwa Y; Kakinoki M; Sawada T; Wang X; Ohji M
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6501-5. PubMed ID: 26447985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model.
    Christoforidis JB; Briley K; Binzel K; Bhatia P; Wei L; Kumar K; Knopp MV
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5636-5645. PubMed ID: 29094168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INTRAVITREAL ZIV-AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results.
    de Oliveira Dias JR; Costa de Andrade G; Kniggendorf VF; Novais EA; Takahashi VKL; Maia A; Meyer C; Watanabe SES; Farah ME; Rodrigues EB
    Retina; 2019 Apr; 39(4):648-655. PubMed ID: 29232334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT.
    Christoforidis JB; Williams MM; Kothandaraman S; Kumar K; Epitropoulos FJ; Knopp MV
    Curr Eye Res; 2012 Dec; 37(12):1171-4. PubMed ID: 22991959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of subconjunctival aflibercept in treating choroidal neovascularization.
    Nirmal J; Barathi VA; Dickescheid A; Wey YS; Nirmal S; Raja MM; Venkatraman S; Agrawal R
    Exp Eye Res; 2020 Oct; 199():108187. PubMed ID: 32795527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLATTENING OF A TREATMENT-RESISTANT RETINAL PIGMENT EPITHELIAL DETACHMENT AFTER A SINGLE INTRAVITREAL INJECTION OF ZIV-AFLIBERCEPT.
    Yogi R; Stewart M; Chhablani J
    Retin Cases Brief Rep; 2017 Spring; 11(2):111-113. PubMed ID: 27078613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR THE TREATMENT OF A PATIENT WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.
    Andrade GC; Dias JRO; Maia A; Farah ME; Mitne S; Rodrigues EB
    Retin Cases Brief Rep; 2018 Spring; 12(2):93-96. PubMed ID: 29554051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Macular Thickness and Visual Acuity in DME Treated by Two Doses of Intravitreal Ziv-Aflibercept Versus Bevacizumab: Analysis of a Randomized, Three-Armed Clinical Trial.
    Jabbarpoor Bonyadi MH; Baghi A; Ramezani A; Yaseri M; Soheilian M
    Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):684-690. PubMed ID: 31755967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Fc Region in the Vitreous Half-Life of Anti-VEGF Drugs.
    Joo K; Park SJ; Choi Y; Lee JE; Na YM; Hong HK; Park KH; Kim HM; Chung JY; Woo SJ
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4261-4267. PubMed ID: 28850637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.